NANO. Betalutin, at the big pharma table.


6 mars 2019 - Dr. Reza Safaei, Head, Medical Affairs, Nordic Nanovector

Betalutin. An Antibody-radionuclide-conjugate (ARC) for the Treatment of Relapsed Non-Hodgkin’s Lymphoma

¤ Introduction to Nordic Nanovector ASA
¤ Introduction to Betalutin
¤ Summary of clinical data and development program of Betalutin


World ADC London, is Europe's leading antibody-drug conjugate conference.


https://imgur.com/a/xw0Rqj4

Det bildet der! Bra.

Men det slår ikke denne : 0:20

https://www.youtube.com/watch?v=ithVo4q6Aik